Mutual Funds
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
10.67   -0.07
NAV(₹) as on 4/9/2026 		-0.67%
  1D 		9.09%
  1Y 		   -
  3Y 		   -
  5Y
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
2.78 		Launch Date:
27 Jun 2025
Exit Load:
NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y 		AUM:
₹ 519.48 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
10.15 		Min. Investment:
SIP : ₹ 500.00
Lumpsum : ₹ 1,000.00
Scheme Benchmark:
NA
Fund Manager:
Sanjay Chawla ,Ankeet Pandya

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 31/7/2026 3.39 % 96.61 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
8.82 %

Torrent Pharmaceuticals Ltd.
8.58 %

Divi's Laboratories Ltd.
6.66 %

Lupin Ltd.
6.46 %

Ipca Laboratories Ltd.
5.72 %

Apollo Hospitals Enterprise Ltd.
5.35 %

Laurus Labs Ltd.
5.24 %

Fortis Healthcare Ltd.
4.55 %

Astrazeneca Pharma India Ltd.
4.05 %

Glenmark Pharmaceuticals Ltd.
3.44 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
72.13 %

Hospital & Healthcare Servic
19.70 %

Finance - Others
2.27 %

IT - Software
1.42 %

Retailing
1.09 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2025-26
NAV (31/3/2026) 9.10
Net Assets (Rs Crores) 51,519.31
Scheme Returns(%)(Absolute) -8.96
B'mark Returns(%)(Absolute) NA
Category Rank 98/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.91   +-0.06  
11/12/2023 ₹ 682.39 25.21% - - 21.17%
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  21.64   +-0.08  
4/10/2023 ₹ 2,939.98 25.51% - - 30.42%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.78   +-0.11  
6/2/2024 ₹ 824.9 19.97% - - 22.24%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  12.10   +-0.10  
6/12/2024 ₹ 111.64 22.47% - - 11.54%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.80   +-0.06  
27/12/2024 ₹ 376.77 19.98% - - 10.28%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.67   +-0.07  
27/6/2025 ₹ 519.48 9.09% - - 5.62%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.22   +-0.03  
28/11/2025 ₹ 319.48 - - - 12.23%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  18.04   +-0.11  
8/11/2021 ₹ 262.84 11.09% 18.29% - 13.01%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  570.74   +-3.30  
5/6/2004 ₹ 9,279.11 10.69% 18.29% 12.52% 19.92%
MDB Logo
Tata India Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  33.43   +-0.16  
28/12/2015 ₹ 1,541.42 8.54% 18.94% 12.92% 11.95%